First GMP Warning Letter Reflects FDA's List Of Major Concerns
This article was originally published in The Tan Sheet
Executive Summary
FDA's first warning letter concerning dietary supplement good manufacturing practices advises Coats International Holdings to follow written procedures, improve documentation and conduct appropriate identity tests
You may also be interested in...
FDA 'Program Alignment' Means Inspections Consistency To Supplement Industry
Reports are common about ORA officials not being knowledgeable about the agency's supplement manufacturing and marketing regulations or familiar with the commodity of dietary supplements, but relying on drug or food product manufacturing regulations when they inspect supplement facilities.
Supplement Firms Confounded By Identity Testing Waiver Process
FDA says it has not received any petitions to request an exemption from the 100% supplement ingredient identity testing requirement. Food and drug attorneys say the hassle of preparing a petition for a waiver outweighs the potential benefits
Supplement Firms Confounded By Identity Testing Waiver Process
FDA says it has not received any petitions to request an exemption from the 100% supplement ingredient identity testing requirement. Food and drug attorneys say the hassle of preparing a petition for a waiver outweighs the potential benefits